Tiny RNA fragments can predict two-year survival better than traditional health metrics. Researchers from Duke Health and the ...
Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion’s strategic shift to advancing clinically proven ...
For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results